£153.33

It has never been this cheap. We have no record of a lower price.

£153 today · cheaper than every other day in the last 2 months

Horizons in Cancer Research. Volume 84

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 13 days · 13 data points (no recent data)

Historical
Generating forecast…
£153.33 £145.66 £148.73 £151.80 £154.86 £157.93 £161.00 18 August 2026 21 August 2026 24 August 2026 27 August 2026 30 August 2026
View at Amazon ↗

Price data last checked 52 day(s) ago - refreshing...

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 13 days • 1 price levels

Days at Price
13 days 0 3 7 10 13 £153 Days at Price

Price Analysis

Most common price: £153 (13 days, 100.0%)

Price range: £153 - £153

Price levels: 1 different prices over 13 days

Description

This volume includes eight chapters that describe recent updates in cancer research. Chapter One highlights the benefits of ancillary/consulting care services within pediatric oncology, including social work, psychology, neuropsychology, expressive therapies, child life, chaplaincy, teachers/school liaisons, rehabilitation therapies, nutrition, and palliative care. Chapter Two discusses various generations of chimeric antigen receptors (CAR) and recent efforts in manufacturing CAR T-cells as a therapy for cancer treatment. Chapter Three explores alternative target pathways for putative therapeutic approaches affecting chronic myeloid leukemia cells. Chapter Four reviews research done on the role of epigenetics in the initiation and progression of thyroid cancer. Chapter Five summarizes the literature that implicates the underlying molecular mechanisms of paclitaxel resistance and the potential therapeutic targets to overcome this resistance. Chapter Six deals with the inhibition of autophagy for instigating temozolomide for increasing induction of apoptosis in glioblastoma. Chapter Seven studies the use of vitamin E for leukemic stem cells reprogramming. Finally, Chapter Eight describes new molecular studies for approaches affecting chronic myeloid leukemia cells.

Product Specifications

Format
hardcover
Domain
Amazon UK
Release Date
01 September 2022
Listed Since
04 August 2022

Barcode

No barcode data available

Similar Products You Might Like

Horizons in Cancer Research: Volume 78 (Horizons in Cancer Research)
86% match

Horizons in Cancer Research: Volume 78 (Horizons in Cancer Research)

£169.50 31 Aug 2026
Horizons in Cancer Research: v. 43: Volume 43
85% match

Horizons in Cancer Research: v. 43: Volume 43

£157.99 31 Aug 2026
Horizons in Cancer Research: v. 41: Volume 41
83% match

Horizons in Cancer Research: v. 41: Volume 41

£128.24 09 Aug 2026
Non-Small Cell Lung Cancer: New Research (Cancer Etiology, Diagnosis and Treatments)
81% match

Non-Small Cell Lung Cancer: New Research (Cancer Etiology, Diagnosis and Treatments)

£66.33 05 Aug 2026
New Topics in Cancer Research (Horizons in Cancer Research)
81% match

New Topics in Cancer Research (Horizons in Cancer Research)

Brand: Nova Biomedical Books

£147.96 06 Aug 2026
Molecular Oncology: Underlying Mechanisms and Translational Advancements
80% match

Molecular Oncology: Underlying Mechanisms and Translational Advancements

Springer

£80.67 05 Aug 2026
Horizons in Cancer Research. Volume 81 (Horizons in Cancer Research)
80% match

Horizons in Cancer Research. Volume 81 (Horizons in Cancer Research)

£170.99 14 Aug 2026
80% match

Molecular Mechanisms of Cancer Resistance: Emerging Technologies and Therapeutic Strategies (Novel approaches to overcome cancer resistance to conventional therapies)

Elsevier

£153.99 05 Aug 2026
Molecularly Targeted Therapy for Childhood Cancer
79% match

Molecularly Targeted Therapy for Childhood Cancer

Springer

£148.21 17 Aug 2026
Advances in Cancer Research (Volume 137)
79% match

Advances in Cancer Research (Volume 137)

Elsevier

£104.77 30 Aug 2026
Horizons in Cancer Research. Volume 82 (Horizons in Cancer Research)
79% match

Horizons in Cancer Research. Volume 82 (Horizons in Cancer Research)

£221.99 12 Aug 2026
Gene and Cellular Immunotherapy for Cancer (Cancer Drug Discovery and Development)
79% match

Gene and Cellular Immunotherapy for Cancer (Cancer Drug Discovery and Development)

Humana

£108.01 13 Aug 2026
Molecular Targeting in Oncology (Cancer Drug Discovery and Development)
79% match

Molecular Targeting in Oncology (Cancer Drug Discovery and Development)

Humana

£148.21 05 Aug 2026
Drug Resistance in Cancer Therapy: 48 (Cancer Treatment and Research, 48)
79% match

Drug Resistance in Cancer Therapy: 48 (Cancer Treatment and Research, 48)

Springer

£113.76 05 Aug 2026
Cancer Chemotherapy 1: 7 (Cancer Treatment and Research)
79% match

Cancer Chemotherapy 1: 7 (Cancer Treatment and Research)

Springer

£166.02 07 Aug 2026
Stem Cells in Cancer: Should We Believe or Not?
79% match

Stem Cells in Cancer: Should We Believe or Not?

Springer

£110.18 13 Aug 2026
Cancer Gene Therapy (Contemporary Cancer Research)
79% match

Cancer Gene Therapy (Contemporary Cancer Research)

Humana

£169.87 06 Aug 2026
Novel therapeutic approaches for gastrointestinal malignancies (Diagnostics and Therapeutic Advances in GI Malignancies)
79% match

Novel therapeutic approaches for gastrointestinal malignancies (Diagnostics and Therapeutic Advances in GI Malignancies)

Springer

£74.67 29 Aug 2026
Pharmaceutical Perspectives of Cancer Therapeutics
79% match

Pharmaceutical Perspectives of Cancer Therapeutics

Springer

£179.99 08 Aug 2026
Nutraceuticals and Cancer
79% match

Nutraceuticals and Cancer

Springer

£113.76 05 Aug 2026
Drug Targets in Cellular Processes of Cancer: From Nonclinical to Preclinical Models
79% match

Drug Targets in Cellular Processes of Cancer: From Nonclinical to Preclinical Models

Springer

£74.57 08 Aug 2026
Supportive Care in Cancer Therapy: 13 (Cancer Treatment and Research, 13)
79% match

Supportive Care in Cancer Therapy: 13 (Cancer Treatment and Research, 13)

Springer

£113.76 12 Aug 2026
New Perspectives in Molecular and Clinical Management of Gastrointestinal Tumors: 142 (Recent Results in Cancer Research, 142)
79% match

New Perspectives in Molecular and Clinical Management of Gastrointestinal Tumors: 142 (Recent Results in Cancer Research, 142)

Springer

£76.42 30 Aug 2026
Gene-Based Therapies for Cancer (Current Cancer Research)
79% match

Gene-Based Therapies for Cancer (Current Cancer Research)

Springer

£108.01 06 Aug 2026